Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
Octreotide
3D-Ansicht

Biosynth logo

Octreotide

Ref. 3D-PP49921

Unbestimmte GrößeNachfragen
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 10. Dezember 2024

Produktinformation

Name:
Octreotide
Beschreibung:

Peptide Octreotide is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Octreotide include the following: Synthesis and in vitro study of the anticancer activity of new analogs of octreotide S Staykova, E Naydenova - Protein and Peptide , 2012 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/ppl/2012/00000019/00000012/art00004 Extended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro release RD Vaishya, A Mandal , S Patel , AK Mitra - International journal of , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378517315303525 Long-term follow-up of renal function after peptide receptor radiation therapy with 90Y-DOTA0, Tyr3-octreotide and 177Lu-DOTA0, Tyr3-octreotate R Valkema, SA Pauwels, LK Kvols - Journal of nuclear , 2005 - Soc Nuclear Medhttps://jnm.snmjournals.org/content/46/1_suppl/83S.short Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0, Tyr3] octreotide in patients with advanced gastroenteropancreatic R Valkema, S Pauwels, LK Kvols, R Barone - Seminars in nuclear , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S000129980600002X Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0] octreotide: the Rotterdam experience R Valkema, M De Jong, WH Bakker - Seminars in nuclear , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0001299802800290 Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland R Deghenghi, M Papotti, E Ghigo, G Muccioli - Endocrine, 2001 - Springerhttps://link.springer.com/article/10.1385/ENDO:14:1:029 Gold nanoparticles conjugated to [Tyr3] octreotide peptide PP Surujpaul , C Gutierrez-Wing, B Ocampo-Garcaca­a - Biophysical , 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0301462208001737 Octreotide: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion PE Battershill, SP Clissold - Drugs, 1989 - Springerhttps://link.springer.com/article/10.2165/00003495-198938050-00002 Analytical quality-by-design optimization of UHPLC method for the analysis of octreotide release from a peptide-based hydrogel in-vitro PD Tzanavaras , AT Chatzitaki , C Karavasili - of Pharmaceutical and , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0731708522001200 A novel facile method of labeling octreotide with 18F-fluorine P Laverman, WJ McBride, RM Sharkey - Journal of nuclear , 2010 - Soc Nuclear Medhttps://jnm.snmjournals.org/content/51/3/454.short Effect of conformation on the photodegradation of Trp-and cystine-containing cyclic peptides: octreotide and somatostatin O Mozziconacci, C Schöneich - Molecular pharmaceutics, 2014 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/mp5003174 Octreotide-mediated tumor-targeted drug delivery via a cleavable doxorubicin-peptide conjugate M Lelle, S Kaloyanova, C Freidel - Molecular , 2015 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.5b00487 Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy M De Jong, WH Bakker, WAP Breeman - journal of cancer, 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0215(19980130)75:3%3C406::AID-IJC14%3E3.0.CO;2-6 Tumour uptake of the radiolabelled somatostatin analogue [DOTA0,TYR3]octreotide is dependent on the peptide amount M de Jong, WAP Breeman, BF Bernard - European journal of , 1999 - Springerhttps://link.springer.com/article/10.1007/s002590050439 213Bi-[DOTA0, Tyr3]Octreotide Peptide Receptor Radionuclide Therapy of Pancreatic Tumors in a Preclinical Animal Model JP Norenberg , BJ Krenning, IRHM Konings - Clinical Cancer , 2006 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/12/3/897/194211 Comparison of [177Lu-DOTA0,Tyr3]octreotate and [177Lu-DOTA0,Tyr3]octreotide: which peptide is preferable for PRRT? JP Esser, EP Krenning, JJM Teunissen - European journal of , 2006 - Springerhttps://link.springer.com/article/10.1007/s00259-006-0172-9 Gastrointestinal peptide hormones during postoperative ileus: Effect of octreotide JJ Cullen, JC Eagon, KA Kelly - Digestive diseases and sciences, 1994 - Springerhttps://link.springer.com/article/10.1007/BF02093781 Reversible blocking of amino groups of octreotide for the inhibition of formation of acylated peptide impurities in poly (lactide-co-glycolide) delivery systems JH Ahn, EJ Park, HS Lee, KC Lee, DH Na - Aaps Pharmscitech, 2011 - Springerhttps://link.springer.com/article/10.1208/s12249-011-9694-y Octreotide G Stajich , L Ashworth - Neonatal Network, 2006 - connect.springerpub.comhttps://connect.springerpub.com/content/sgrnn/25/5/365.abstract Production of peptides as generic drugs: a patent landscape of octreotide G Sabatino , I Guryanov, A Rombecchi - Expert Opinion on , 2016 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1517/13543776.2016.1158810 Enteral absorption of octreotide G Flicker, J Drewe , J Vonderscher - British journal of , 1992 - Wiley Online Libraryhttps://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1476-5381.1992.tb09057.x Peroral delivery systems based on superporous hydrogel polymers: release characteristics for the peptide drugs buserelin, octreotide and insulin FA Dorkoosh , JC Verhoef, MHC Ambagts - European journal of , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0928098702000283 Structure of octreotide, a somatostatin analogue E Pohl, A Heine, GM Sheldrick , Z Dauter - Section D: Biological , 1995 - scripts.iucr.orghttps://scripts.iucr.org/cgi-bin/paper?gr0269 Evaluation of [99mTc/EDDA/HYNIC0] octreotide derivatives compared with [111In-DOTA0, Tyr3, Thr8] octreotide and [111In-DTPA0] octreotide: does tumor or D Storch, M Behe , MA Walter , J Chen - Journal of nuclear , 2005 - Soc Nuclear Medhttps://jnm.snmjournals.org/content/46/9/1561.short Versatile conjugation of octreotide to dendrimers by cycloaddition ("œclick") chemistry to yield high-affinity multivalent cyclic peptide dendrimers CB Yim, OC Boerman, M de Visser - Bioconjugate , 2009 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bc900052n A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a C Parkinson, WM Drake, ME Roberts - The Journal of , 2002 - academic.oup.comhttps://academic.oup.com/jcem/article-abstract/87/4/1797/2374984 From bulk to plasmonic nanoparticle surfaces: the behavior of two potent therapeutic peptides, octreotide and pasireotide B Hernandez , E Lopez-Tobar - Physical Chemistry , 2016 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2016/cp/c6cp04421b Controlled release of octreotide and assessment of peptide acylation from poly (D, L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres AH Ghassemi, MJ van Steenbergen - Pharmaceutical , 2012 - Springerhttps://link.springer.com/article/10.1007/s11095-011-0517-3 Peptide receptor radionuclide and octreotide: a novel approach for metastatic tumor-induced osteomalacia A Nair , S Chakraborty, P Dharmshaktu - Journal of the , 2017 - academic.oup.comhttps://academic.oup.com/jes/article-abstract/1/6/726/3788875 Locoregional Regulatory Peptide Receptor Targeting with the Diffusible Somatostatin Analogue 90Y-Labeled DOTA0-d-Phe1-Tyr3-octreotide (DOTATOC): A Pilot A Merlo, O Hausmann, M Wasner, P Steiner, A Otte - Clinical cancer , 1999 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/5/5/1025/287501 Peptide receptor radionuclide therapy in vitro using [111In-DTPA0] octreotide A Capello, EP Krenning, WAP Breeman - Journal of Nuclear , 2003 - Soc Nuclear Medhttps://jnm.snmjournals.org/content/44/1/98.short Nanoparticles containing octreotide peptides and gadolinium complexes for MRI applications A Accardo , A Morisco, E Gianolio - Journal of peptide , 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.1308

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP49921 Octreotide

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.